BDI Seminar: Genomics and drug discovery
I will discuss the use of genomics and data science in drug discovery at GSK, and particularly in the selection and validation of drug targets. I’ll highlight the interplay between experimental science and informatics, and will discuss recently published work highlighting the value of genetic information in selecting drug targets/indications. Motivated by this, I will also include a sketch of work ongoing and planned in this area at GSK, particularly with respect to the potential to integrate electronic health record and genomics information. I will also describe work at Open Targets (, including both experimental and informatics aspects. I will focus on the key concepts and avoid technical detail, both regarding genomics and data science.
Date: 7 September 2017, 10:00 (Thursday, 20th week, Trinity 2017)
Venue: Big Data Institute, Old Road Campus OX3 7LF
Venue Details: BDI LG Seminar Room 0
Speaker: Dr John Whittaker (VP Statistical Tech/Platforms, Target Sciences, GSK)
Organising department: Big Data Institute
Organiser: Natasha Bowyer (University of Oxford, Nuffield Department of Population Health)
Part of: BDI seminars
Booking required?: Not required
Audience: Members of the University only
Editors: Graham Bagley, Natasha Bowyer